You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Neoplasm (MPN)

Showing 1 - 25 of 937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

    Withdrawn
    • Accelerated Phase MPN
    • Blast Phase MPN
    • (no location specified)
    Nov 4, 2022

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis，MF
    • flonoltinib 25mg
    • +5 more
    • Chengdu, Sichuan, China
      West China Hospital Sichuan University
    Mar 9, 2022

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasm
    • Azacitidine Subcutaneous Injection or Intravenous Infusion
    • +2 more
    • Miami, Florida
    • +4 more
    Jun 20, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Not yet recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis，MF
    • flonoltinib 25mg
    • +5 more
    • (no location specified)
    Nov 2, 2021

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    Jan 10, 2022

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

    Completed
    • Myelodysplastic/Myeloproliferative Neoplasm
    • +2 more
    • Decidual stromal cells (DSC)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Myeloproliferative Tumor Trial in New York (Vactosertib)

      Recruiting
      • Myeloproliferative Neoplasm
      • New York, New York
        Weill Medical College of Cornell University
      Dec 20, 2021

      MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

      Recruiting
      • MDS/MPN
      • Azacitidine (AZA) with Ruxolitinib
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical University
      Apr 17, 2023

      Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

      Not yet recruiting
      • Myeloproliferative Disorders
      • Leukemia
      • Cardiac Lifestyle Program
      • Boston, Massachusetts
      • +2 more
      May 1, 2023

      Myeloproliferative Neoplasms (MPN) and COVID-19

      Recruiting
      • Myeloproliferative Neoplasm
      • COVID
        • New York, New York
        • +43 more
        Apr 4, 2022

        Myeloproliferative Tumor Trial in Irvine (Diet intervention)

        Completed
        • Myeloproliferative Neoplasm
        • Diet intervention
        • Irvine, California
          University of California, Irvine
        Jun 16, 2022

        Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

        Recruiting
        • Iron Deficiency Anemia
        • Adelaide, South Australia, Australia
        • +8 more
        Jun 23, 2023

        Monocytes Sub-populations in Thrombosis Associated With

        Recruiting
        • Myeloproliferative Neoplasm
        • 1 additional tube of blood
        • Bordeaux, France
        • +4 more
        Nov 30, 2022